Aim: To compare serum paraoxonase/arylesterase (PON-aryl) activities in phenylketonuric (PKU) patients with high and low phenylalanine (Phe) blood concentration. Patients and methods: Seventeen poorly controlled PKU children (off diet) underwent clinical and laboratory examinations before and after 30 days adhering to their special diet (on diet), whereas controls (N ¼ 24) were examined once. Lipid, lipoprotein levels and paraoxonase (PON 1) activities were measured with the Bayer Advia 1650 Clinical Chemistry System. Apolipoprotein AI (Apo AI) levels were determined by the Dade Behring BN ProSpec nephelometer, whereas total antioxidant capacity (TAC), PON-aryl and Phe levels were measured spectrophotometrically. Results: Phe significantly differed among the groups. Lipids and lipoproteins, except high-density-lipoprotein-cholesterol (HDL-C) and Apo AI, were higher when off diet than those on diet. HDL-C and Apo AI were similar in patients and controls. TAC (0.9970.19 mmol/l) was significantly lower when the patients were off diet than when they adhered to diet and controls (1.7170.20 and 1.8170.20 mmol/l Po0.001 respectively). PON 1 and PON-aryl activities (6872 U/min/ml, 88726 KU (min/ ml) in children with high Phe were reduced as compared with those with low blood Phe levels (152741 U/min/ml, 107723 KU/ min/ml Po0.001) and controls (146743 U/min/ml, 109741 KU/min/ml Po0.001). The enzyme activities positively correlated with HDL-C and Apo AI when PKU patients were on diet and controls as well as with TAC in all the groups, whereas negatively correlated with Phe levels. Conclusions: PON-aryl activities are strongly related to the dietary control of PKU patients.
Introduction
Paraoxonase/arylesterase, (PON-aryl) associated with highdensity lipoprotein (HDL), were initially identified for their abilities to hydrolyze organophosphate compounds and aromatic carboxylic esters. Recent interest in the enzymes has arisen from the idea that PON 1 protects low-density lipoprotein (LDL) and HDL from lipid peroxidation (La Du, 1996) . This protection was proposed to be related to the peroxidase-like activity of PON 1 on preexisting peroxides and the ability of paraoxonase (PON 1) to modify the proportion of oxidation products in oxidized LDL (Mackness et al., 1996; Josse et al., 2001; Duy Nguyen and Dai Eun, 2003) and an increased risk of atherosclerosis. In studies with PON 1 knockout mice, PON 1 was shown to be both necessary for the in vitro protective effects of HDL on LDL oxidation (Watson et al., 1995; Aviram et al., 1999) . Recent clinical investigations indicate that PON 1 activity is lower in subjects with coronary heart diseases than control subjects (La Du, 1996; Duy Nguyen and Dai Eun, 2003) . Despite the association of PON 1 activity with the prevention against LDL oxidation (La Du, 1996; Mackness et al., 1996) , the mechanism by which PON 1 inhibits the oxidation of LDL phospholipids is not clear. Hydrogen peroxide (H 2 O 2 ) at millimolar concentrations was observed to partially inactivate PON 1 (Aviram et al., 1998; Aviram et al., 2000) .
Recently, it was suggested that the enhanced inactivation of HDL-bound PON 1 in glycoxidative condition was ascribed to free radicals-induced oxidation. Besides a, b-unsaturated aldehydes stable decomposition products of lipid peroxides, which gradually accumulate in the later stage of LDL oxidation could also cause the inactivation of PON 1 (McCall et al., 1995; Aviram et al., 1998) . Thus, PON 1 is speculated to be one of the antioxidant enzymes very susceptible to oxidative stress in in vivo system. Additionally, under oxidative stress conditions, HDL constitutes a target for oxidative modifications that may affect their antioxidant properties (Berliner and Heinecke, 1996) . It should also be noted that PON 1 activity is strongly dependent on its stability, which is enhanced in a phospholipids environment and in association with Apo AI (Burkitt, 2001; Marathe et al., 2003) .
Classical phenylketonuric (PKU) is an inborn error of metabolism characterized by the deficiency of the enzyme phenylalanine (Phe) hydroxylase. Consequences of this deficiency are the elevated blood concentrations of the amino acid Phe and the low or normal concentration of tyrosine. Mental retardation and eczema are the main clinical findings in untreated patients (Burgard et al., 1996; Scriver et al., 2000) . PKU is currently treated by a special diet to avoid elevated blood levels of the amino acid. Because of the severe restriction of conventional foods, supplements of amino acids, other than Phe, protein free energy sources and macro trace minerals are necessary to ensure the adequacy of the diet. The quantity of natural protein intake (Phe intake) is individualized and depends on the residual activity of the enzyme Phe hydroxylase (Scriver et al., 2000) . These protein requirements are achieved generally with vegetable proteins. Such a diet can be defined as 'non-atherogenic' because of the reductions of animal lipids, cholesterol, saturated fatty acids and increased intake of dietary fiber. All these factors have well-known effects on lipid control (Francis, 1989) .
In our previous studies (Schulpis and Scarpalezou, 1989; Schulpis et al., 2004) , blood cholesterol levels were found low in PKU patients on diet as compared to those of healthy children of the same age. In contrast, their triacylglycerol levels were higher as a result of their special diet containing a large amount of carbohydrates.
Recently, we reported that the high antioxidant capacity in patients with PKU with a good compliance with their diet is possibly owing to the large amounts of antioxidants which are present in their special low Phe vegetarian diet. In contrast, low plasma antioxidant capacity was found in the plasma of PKU patients who did not adhere to their therapeutic diet, on 'a loose diet' (Schulpis et al., 2003) . Additionally, we reported (Vlachos et al., 2006) low PON 1 activity in the sera of mothers in prolonged labor and low plasma antioxidant capacity.
As PKU therapeutic diet is a life long diet and PON-aryl activities are closely related to lipids, especially HDL, Apo AI and oxidation, we aimed to investigate the antiatherogenic enzyme activities in patients with phenylketonuria.
Patients and methods
The present study was approved by the Greek Ethics Committee and was conducted according to the Declaration of Helsinki Principles.
Patients
Seventeen (N ¼ 17) PKU patients, males (N ¼ 10), females (N ¼ 7), mean age 6.871.4 years were diagnosed by 'screening' and were put on the special diet after tetrahydrobiopterine (BH 4 ) loading test and dehydropteridine reductase evaluation. Their daily protein intake, was largely replaced by PKU 2 Prima (Milupa AG), which is a Phe-free mixture of amino acids enriched by vitamins and trace elements. The product contains no fat of any kind. Olive oil was the main source of their fat intake.
Patients and Controls (N ¼ 24) underwent standard laboratory tests, (blood count, C-reactive protein (CRP), liver enzymes, urine specimen etc) to exclude any subclinical infection processes before enrolling into the study. The study patients with PKU, who did not adhere to their therapeutic diet (off diet), for the previous 3 months, as evidenced by their high Phe levels (17607160 mmol/l) in their blood, were requested to follow their diet strictly for 30 days (on diet), mean Phe 4927100 mmol/l and then they were re-evaluated.
Regular consumers of any medication or vitamin supplements were excluded from the Control group, whereas PKU patients were requested to discontinue their vitamin supplementation for the last 30 days. In addition dietetic diary was kept for each PKU patient and controls for 30 successive days. Nutritional tables (Paul et al., 1980) were used for the calculation of their dietary records.
Methods Blood (6.0 ml) was drawn from each member of the three groups after 8-10 h fasting for the evaluation of Phe, cholesterol (t-Chol), triacylglycerol (TG), HDL-C, LDL-C, very low density lipoprotein-cholesterol (VLDL-C), Apolipoprotein AI (Apo AI), total antioxidant capacity (TAC) and PON-aryl serum activities at the beginning and at the end of the study, whereas controls were examined once.
Phe was measured with a standardized enzymatic assay in dried blood samples on filter paper (Schleicher-Schull 903) with R and D diagnostics MMR-2000 (Wendel et al., 1990) .
Analytical procedure
Blood chemistry including determinations of t-Chol, TG, HDL-C, LDL-C and very low-density lipoprotein cholestrol (VLDL-C) was performed using the Bayer ADVIA 1650 clinical chemistry analyzer (Bayer Corporation, Tarrytown, NY, USA). Internal quality control of the lipids was carried out according to the laboratory manual of the Lipid Research Clinics Programme (1974) . Cholesterol bound to VLDL and LDL was estimated by the Friedewald equation. Apo AI levels were determined by latex particle-enhanced immunonephelometric assays on the BN ProSpec nephelometer (Dade Behring, Liederbach, Germany). Quality control has previously been indicated. Interassay coefficients variation for t-Chol, TG, HDL-C and Apo AI, were 3.5, 3.7, 5.1 and 5.0%, respectively. TAC was measured in plasma as reported previously by Miller et al. (1993) . Plasma was frozen for up to 14 days before analysis. 2,2 0 -azino-di-3-ethylbenzthiazoline sulphonate (ABTS) was incubated with peroxidase (metmyoglobin) and H 2 O 2 to produce the radical cation ABTS þ , which was a relatively stable, blue-green colour measured spectrophotometrically at 600 nm. Antioxidants in the added sample cause suppression of the above color production to a degree proportional to their concentration. The assay range was 0-2.5 mmol/l. Samples with concentrations 42.5 mmol/l were diluted with 0.9% sodium chloride (NaCl) and reassayed. According to Strube et al. (1997) , the present method calculates both the radical scavenging effect and the effect on the rate of ABTS oxidation. Interassay and intraassay variations were 2.8 and 3.9% respectively. PON 1 activity toward paraoxon (O,O-diethyl-O-p-nitrophenyl phosphate from Sigma-Aldrich Co, St Louis, MI, USA) was measured after the reaction of paraoxon hydrolysis into p-nitrophenol and diethylphosphate as described previously (Charlton-Menys et al., 2006) . PON 1 assays were performed in the absence of NaCl (baseline activity) in a buffer containing 90 mM Tris-HCl (pH 8.5), 1.5 mM CaCl 2 and 2.5 mM paraoxon. We measured the rate of hydrolysis of paraoxon by monitoring the increase of absorbance at 410 nm and 371C in the Bayer Advia 1650 Clinical Chemistry System (Bayer Corporation, Tarrytown, NY, USA), (Vlachos et al., 2006) . Frozen aliquots of a serum pool were used as an internal control. At least one aliquot of the serum pool was measured in every 10 samples in order to correct for interassay variations. 1 U/ml of PON 1 was defined as 1 nmole of p-nitrophenol formed per minute. The interand intra-assay coefficients of variation were 1.4 and 1.9% respectively. PON-aryl was determined spectrophotometrically in an assay buffer containing 1 mM phenylacetate, 20 mM Tris-HCl (pH 8.0) and 1 mM CaCl 2 . Serum samples were prediluted 1:8. Blanks without enzyme, were used to correct for spontaneous hydrolysis. Frozen aliquots of a serum pool, used as an internal control, were thawed just before the beginning of the assay. One sample of serum pool was measured every 10 samples. Activity was calculated by measuring the increase of absorbance at 270 nm at UNICAM UV2 VIS/UV spectrophotometer, using the molar extinction coefficient 1310 M À1 cm
À1
. One U/ml of PON-aryl was defined as a micromole of phenylacetase hydrolyzed per minute (Senti et al., 2003; Charlton-Menys et al., 2006) .
Statistical analysis
ANOVA followed by a post hoc test (Tukey's test) were used for the analysis of the results, Spearmann-rank test was utilized for the estimation of coefficient variations. All the statistical procedures were performed using the STATGRAFICS PLUS version 5.1 for Windows program (Graphic Software System). Statistical significance was stated at Po0.05.
Results
As shown in Table 1 , energy and total protein intake did not differ between the groups, but natural protein, fiber and saturated fat differed greatly. Significant, differences were also found in the intake of total fat, saturated, monounsaturated and polyunsaturated fat, and cholesterol between patients on diet and controls as well as between the two groups of patients.
As presented in Table 2 , Phe, t-Chol, VLDL-C, LDL-C and the ratio t-Chol/HDL-C, significantly differed in patients on diet as compared to those of group A and Controls. PON 1 and PON-aryl activities as well as TAC were significantly reduced in patients off diet as compared with those of patients on diet and controls. The other biochemical parameters were similar among the groups.
As illustrated in Table 3 , significantly positive correlations were found between the enzymes and HDL-C and Apo A I in patients on diet and controls. In addition, remarkably positive correlations were found between PON 1, PON-aryl and TAC, whereas the enzymes negatively correlated with Phe in all the studied groups.
Discussion
Over the last three decades biomedical literature has implicated free radicals in many pathological conditions. The harmful effects of free radicals lead to oxidative stress of the cells, if not neutralized by antioxidants (Halliwell and Gutterdge, 1989) . Plasma lipoprotein abnormalities underlie and may even be essential for the common occurrence of atherosclerotic vascular diseases. The abnormalities include elevated concentrations of LDLs and VLDLs and reduced concentrations of HDLs, as generally estimated from measurements of plasma t-Chol, TG and HDL-C. Other studies, however, indicate that the most pronounced lipoprotein abnormalities in patients with early-onset coronary heart disease are high TG and low HDL-C with lesser elevations of LDL-C. In these individuals, the LDL particles are somewhat smaller and denser than in those with a more favorable lipoprotein profile (Reaven and Witzturn, 1996) . PKU patients in patients on diet showed remarkably lower concentrations of t-Chol and LDL-C levels as compared to those of patients off diet and controls (Table 2) . Additionally, the ratio t-Chol/ HDL-C was lower in the same group of patients. This could be due to their vegan-vegetarian diet (Francis, 1989; Schulpis et al., 2004) in which the only sources of lipid intake were olive oil and cream cheese. Other food containing saturated fat, such as eggs, meat etc are contraindicated. The data presented in Table 1 indicate that the intake of these nutrients were remarkably decreased (low saturated fat intake) in the compliant group (on diet) as compared to the patients of the non-compliant group (higher saturated fat intake, (off diet) as well as to the controls who consumed adequate natural protein and lipids as found previously (Schulpis et al., 2004) .
In this study, TAC levels were significantly reduced in patients off diet as compared with those of patients on diet and controls. This finding is possibly owing to the presence of low amounts of antioxidants in the food of poorly controlled patients (Schulpis et al., 2003) . This suggestion is supported by the elevation of their TAC, high TAC, when PKU patients adhered to their diet strictly. In addition, previous (Schulpis et al., 2003 (Schulpis et al., , 2004 and present studies showed that HDL-C and Apo AI levels remained unaltered in both groups of patients whereas LDL-C levels significantly dropped in patients when they follow their diet strictly.
Furthermore PON 1 and PON/aryl activities strongly correlated with HDL-C and Apo AI in PKU patients on strict diet and controls. Also, the antiatherogenic enzyme activities significantly correlated to TAC in all the groups of this study (Table 3) .
To determine whether the above-mentioned associations may be attributed to related alterations in PON 1 and PON/ aryl activities or the alterations of the enzyme activities are causally related to their long-term exposure in oxidative conditions as found in PKU patients off diet, we have postulated three possible explanations: one is that serum PON 1 and PON/aryl activities are lowered as a result of an altered synthesis or secretion of HDL-C. These alterations may result from damaged liver cells, which are not able to express PON 1 and PON/aryl as found in rats with experimental cirrhosis (Ferre et al., 2001) . In this study, HDL-C, Apo AI and liver enzyme function tests were found normal in all the participants. Taken together, our data indicate that PON 1 and PON/aryl activities may be reduced by their long-term exposure in high hydroxyl radicals levels, here presented as low TAC (Jaound et al., 2003; Costa et al., 2005) . In other words, the enzymes, present in relatively high activities in the physiological system, might scavenge these reactive compounds for a long time at least according to stoichiometric removal mechanisms. Therefore, it is likely that hydroxyl radicals may be active species primarily responsible for the oxidative reduction of the PON 1 and PON/aryl in in vivo system. This suggestion is further reinforced by the increase of the enzyme activities when the patients adhere to their therapeutic antioxidant diet strictly and their TAC levels were increased. Finally, we cannot exclude the possibility that high Phe levels might lower the enzyme activities as found in our previous in vitro ( Tsakiris et al., 1998) and in vivo studies (Tsakiris et al., 2002) on an other esterase: high Phe levels decreased both acetylcholinesterase (AChE) activity in rat brain as well as the erythrocyte membrane AChE activity in patients off diet with PKU. We suggest that both low TAC and high serum Phe levels may reduce PON 1 and PON/aryl activities in poorly controlled in patients with PKU.
These findings prove once again that PKU-special therapeutic diet plays a central role not only in the prevention of mental retardation of patients with PKU but also in their protection from LDL oxidation. 
